ZM3278A1 - Pharmacologically active compounds - Google Patents

Pharmacologically active compounds

Info

Publication number
ZM3278A1
ZM3278A1 ZM7832A ZM3278A ZM3278A1 ZM 3278 A1 ZM3278 A1 ZM 3278A1 ZM 7832 A ZM7832 A ZM 7832A ZM 3278 A ZM3278 A ZM 3278A ZM 3278 A1 ZM3278 A1 ZM 3278A1
Authority
ZM
Zambia
Prior art keywords
active compounds
pharmacologically active
pharmacologically
compounds
active
Prior art date
Application number
ZM7832A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB11757/77A external-priority patent/GB1601132A/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZM3278A1 publication Critical patent/ZM3278A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZM7832A 1977-03-19 1978-03-13 Pharmacologically active compounds ZM3278A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11757/77A GB1601132A (en) 1977-03-19 1977-03-19 Pharmacologically active triazinones
GB1182877 1977-03-21

Publications (1)

Publication Number Publication Date
ZM3278A1 true ZM3278A1 (en) 1978-12-21

Family

ID=26248492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZM7832A ZM3278A1 (en) 1977-03-19 1978-03-13 Pharmacologically active compounds

Country Status (15)

Country Link
US (2) US4185103A (xx)
JP (1) JPS53116392A (xx)
AT (1) AT358593B (xx)
AU (1) AU514811B2 (xx)
CA (1) CA1124717A (xx)
CH (1) CH638804A5 (xx)
DE (1) DE2811477A1 (xx)
FR (1) FR2383943A1 (xx)
IE (1) IE46966B1 (xx)
IL (1) IL54111A (xx)
IN (1) IN147613B (xx)
LU (1) LU79266A1 (xx)
NL (1) NL7802959A (xx)
NZ (1) NZ186511A (xx)
ZM (1) ZM3278A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
JPS56115777A (en) * 1980-02-19 1981-09-11 Sumitomo Chem Co Ltd 3-thiooxo-5-oxo-hexahydro-1,2,4-triazine, its preparation, herbicide and germicide comprising it as active ingredient
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
CA1275097A (en) 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
CN103483249A (zh) * 2012-10-09 2014-01-01 南京理工大学 一种2，3，5，6-四氨基吡啶盐酸盐的合成方法
CN104788473B (zh) * 2015-03-25 2017-03-15 石家庄学院 一种具有抗菌能力的化合物及其制备方法与用途
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH288889A (de) * 1950-08-01 1953-02-15 Ag J R Geigy Verfahren zur Herstellung eines Derivates des 1,2,4-Triazins.
GB713540A (en) * 1950-08-01 1954-08-11 Geigy Ag J R Improvements in and relating to 1:2:4-triazine derivatives
DE1670912C3 (de) * 1967-08-18 1981-06-11 Bayer Ag, 5090 Leverkusen Herbizide Mittel auf Basis von 1,2,4-Triazin-5-onen
BE786840A (fr) * 1971-07-29 1973-01-29 Bayer Ag Procede de preparation de 1,2,4-triazine -5-ones
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
IN146736B (xx) 1975-10-02 1979-08-25 Smith Kline French Lab
MW5076A1 (en) 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds

Also Published As

Publication number Publication date
NL7802959A (nl) 1978-09-21
IN147613B (xx) 1980-05-03
IL54111A (en) 1981-07-31
AT358593B (de) 1980-09-25
FR2383943B1 (xx) 1980-08-29
FR2383943A1 (fr) 1978-10-13
CA1124717A (en) 1982-06-01
ATA190478A (de) 1980-02-15
LU79266A1 (fr) 1978-06-29
NZ186511A (en) 1980-11-14
JPS53116392A (en) 1978-10-11
IL54111A0 (en) 1978-04-30
DE2811477A1 (de) 1978-09-21
IE46966B1 (en) 1983-11-16
CH638804A5 (de) 1983-10-14
AU3379278A (en) 1979-09-06
US4185103A (en) 1980-01-22
US4220767A (en) 1980-09-02
AU514811B2 (en) 1981-02-26
IE780542L (en) 1978-09-19

Similar Documents

Publication Publication Date Title
ZA782478B (en) Pharmacologically active compounds
ZA763652B (en) Pharmacologically active compounds
ZA782649B (en) Pharmacologically active compounds
PT67046A (en) Pharmacologically active compounds
PT65590B (en) Pharmacologically active compounds
ZA767198B (en) Pharmacologically active compounds
PT65348B (en) Pharmacologically active compounds
ZA785734B (en) Pharmacologically active compounds
MW977A1 (en) Pharmacologically active compounds
ZA782202B (en) Pharmacologically active compounds
PT65377B (en) Pharmacologically active compounds
ZM3278A1 (en) Pharmacologically active compounds
ZA763837B (en) Pharmacologically active compounds
PT65839A (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
ZA774221B (en) Pharmacologically active compounds
AU2730377A (en) Pharmacologically active compounds
ZA781458B (en) Pharmacologically active compounds
ZA78988B (en) Pharmacologically active compounds
ZA774552B (en) Pharmacologically active compounds
ZA77508B (en) Pharmacologically active compounds
ZA774500B (en) Pharmacologically active compounds
ZA787157B (en) Pharmacologically active compounds
ZM7377A1 (en) Pharmacologically active compounds
MW2876A1 (en) Pharmacologically active compounds